Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Americas Cancer Biologic Therapy Companies

Companies in the Americas specializing in cancer biological therapy contribute to oncology by developing and providing biologically derived therapies for cancer treatment. These therapies may include monoclonal antibodies, immunotherapies, and targeted therapies that harness the body's immune system to combat cancer cells, improving treatment outcomes.

Americas Cancer Biological Therapy Companies

 


Latest Americas Cancer Biological Therapy Companies Updates:


Dec 2023


Bristol-Myers SquibbReceived FDA approval for their Opdivo® (nivolumab) and Yervoy® (ipilimumab) combination therapy for first-line treatment of advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression.Partnered with academic institutions to explore the potential of their biologic therapies for treating additional cancer types and early-stage disease.


Roche Holding AG Announced positive Phase III data for their Tecentriq® (atezolizumab) in combination with chemotherapy for the treatment of advanced bladder cancer.Launched their Foundation® Medicine platform in Brazil, providing personalized genomic testing and treatment recommendations for cancer patients.


Merck & Co.Presented encouraging data at a major oncology conference on their Keytruda® (pembrolizumab) for the treatment of head and neck cancer.Collaborated with government agencies in Latin America to improve access to their cancer biologic therapies for underserved populations.


Eli Lilly and Company Received FDA approval for their Verzenio® (abemaciclib) as a first-line treatment for advanced HR-positive, HER2-negative breast cancer.Announced plans to expand their clinical trial portfolio in the Americas to include more diverse patient populations.


AbbVie Launched their Venclexta® (venetoclax) in combination with Rituximab for the treatment of chronic lymphocytic leukemia (CLL) in Argentina and Brazil.Partnered with patient advocacy groups to raise awareness about CLL and improve access to treatment options.


List of Americas Cancer Biological Therapy Key companies in the market



  • Hoffmann-La Roche AG,

  • GSK, Merck & Co.,

  • Novartis International AG, Inc.,

  • GlaxoSmithKline Plc,

  • Bristol-Myers Squibb,

  • Eli Lilly,

  • Amgen Inc.,

  • Spectrum Pharmaceuticals, Inc.,

  • Seattle Genetics, Inc.,

  • Celgene Corporation


Market Scenario:


The Americas Cancer Biological Therapy market is expected to reach USD 104788.96 Million by 2030 at 7.20% CAGR during the forecast period 2022-2030.Cancer is characterized by uncontrolled growth of cells. It is one of the deadliest disease in the world and the second cause for death. Cancer can be defined as an abnormal cell growth with the potential to spread to other part of the body. There are over 100 types of cancer which has affected human.


Biological therapy uses living organism for the treatment of a disease. These therapies are consist of monoclonal antibodies, vaccines, interferons and many more. Many therapies are available for the treatment of cancer but none of the treatment assure the cure of cancer. The major factors responsible for the growth of the cancer biological therapies are increasing number of patient and limited option of therapy. Bedside this patent expiry of cancer drug increase the demand of the biological treatment. High cost for development of new drug and many adverse effect of the therapy can hamper the market growth. Americas Cancer biologic therapy treatment is expected to grow at CAGR of 7.20% over the forecast period.


Study objectives of Americas Cancer Biological Therapy Market



  • To provide the Detail Overview of parent market.

  • To provide In-depth market segmentation and sub segmentations.

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide Competitive landscape and key players in the market

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to three main geographies and their countries- US, Canada and Rest of America.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Americas Cancer Biological Therapy market.


Intended Audience

  • Cancer Biological Therapy devices manufacturers

  • Cancer Biological Therapy devices suppliers

  • Biotechnology Companies

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Medical Research Institutes


Figure 1- Americas Cancer Biological Therapy Market, By Region Americas Cancer Biologic Therapy Market Share

Key Players for Cancer Biological Therapy Market


Hoffmann-La Roche AG, GSK, Merck & Co., Novartis International AG, Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb, Eli Lilly, Amgen Inc., Spectrum Pharmaceuticals, Inc., Seattle Genetics, Inc., Celgene Corporation and others Segmentation


Americas Cancer Biological Therapy market has been segmented on the basis of-



  • By types which comprises of monoclonal antibodies (Naked monoclonal antibodies, Conjugated monoclonal antibodies, other), interferons, interleukins, cancer growth inhibitors (Tyrosine kinase inhibitors, mTOR inhibitors and Proteasome inhibitors), gene therapy, colony-stimulating factors, targeted therapy, cancer vaccines and others.

  • On the basis of end user, market is segmented into hospitals & clinics, cancer research centers, laboratories and others.

  • And on the basis of Region market is segmented as US, Canada and Rest of America.


Regional Analysis

On regional Basis, America’s biologic cancer therapy market is segmented as US, Canada and Rest of America. The market is dominated by U.S. and Canada due to technological advances and funding available for the development of new therapeutics and treatment. Moreover, increasing number of cancer patient is also driving the market for cancer biologic therapy in this region.


The report for Americas Cancer Biological Therapy market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.